aluates Reports

$ 0.0

Automative

Global AI Imaging & Diagnostics Market Research Report 2026

Published Date: 2026-01-08

Report Code: QYRE-Auto-22S20079

BUY CHAPTERS

Global AI Imaging & Diagnostics Market Research Report 2026

Code: QYRE-Auto-22S20079

Report

2026-01-08

Pages:180

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

AI Imaging & Diagnostics Market Size

The global AI Imaging & Diagnostics market was valued at US$ 7259 million in 2025 and is anticipated to reach US$ 27453 million by 2032, at a CAGR of 20.9% from 2026 to 2032.

AI Imaging & Diagnostics Market

AI Imaging & Diagnostics refers to the integrated market of artificial intelligence technologies applied to medical imaging analysis and broader clinical diagnostic decision-making. It includes AI systems that analyze imaging data such as X-ray, CT, MRI, ultrasound, mammography, and digital pathology, as well as solutions that combine imaging with non-imaging clinical inputs (e.g., physiological signals, structured EHR data) to support diagnosis. These products are typically commercialized as regulated Software as a Medical Device (SaMD) or embedded into imaging equipment and clinical IT systems such as PACS, RIS, and EHRs. AI Imaging & Diagnostics enhances diagnostic accuracy, standardization, and efficiency while keeping physicians in the loop, addressing rising imaging volumes, workforce shortages, and the need for earlier and more consistent disease detection.

The market can be classified by data type (imaging-based, signal-based, multi-modal), by clinical function (detection, segmentation, classification, severity scoring, diagnostic recommendation), by medical specialty (radiology, cardiology, oncology, neurology, ophthalmology, primary care), by deployment model (on-premise, cloud SaaS, device-embedded, edge-based), and by regulatory/commercial type (standalone SaMD, bundled software, clinical decision support, screening-focused solutions). These dimensions reflect both technical complexity and commercial pathways.

Key costs arise from data acquisition and labeling, algorithm development, clinical trials, regulatory compliance, and continuous model updates. With software-centric economics, gross margins generally range from 65% to 80%. Transactions are dominated by subscription SaaS, per-study pricing, and multi-year enterprise licenses, often bundled with imaging systems or workflow platforms. Market trends include rapid regulatory approvals, consolidation through M&A, deeper OEM integration, expansion beyond radiology into multi-disciplinary diagnostics, and accelerating adoption driven by value-based care and clinician shortages.

This report delivers a comprehensive overview of the global AI Imaging & Diagnostics market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding AI Imaging & Diagnostics. The AI Imaging & Diagnostics market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global AI Imaging & Diagnostics market comprehensively. Regional market sizes by Type, by Application, by Diagnostic Data Type, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist AI Imaging & Diagnostics manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of AI Imaging & Diagnostics Market Report

Report Metric	Details
Report Name	AI Imaging & Diagnostics Market
Accounted market size in 2025	US$ 7259 in million
Forecasted market size in 2032	US$ 27453 million
CAGR	20.9%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	X-ray / CXR CT MRI Ultrasound Mammography / DBT Others
Segment by Diagnostic Data Type	Medical Imaging–based Physiological Signals–based Ophthalmic Imaging–based Others
Segment by Deployment & Delivery	On-prem Cloud SaaS Edge / Embedded Hybrid Others
Segment by Application	Radiology & Imaging Cardiology Neurology Ophthalmology Oncology Primary Care Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Butterfly Network, Merative, Tempus, RetinAi, Nanox, Lunit, DiA Imaging, Subtle Medical, BrainMiner, GE, Siemens, Aidoc, Imagen Technologies, Inc., VUNO, Inc., Digital Diagnostics, NeuraSignal, Riverain Technologies, LLC, Philips, Microsoft, Viz.ai, RapidAI, Canon Medical, Enlitic, BioMind, ANNALISE-AI PTY LTD, icometrix, KONFOONG BIOTECH INTERNATIONAL CO., LTD（KFBIO）
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Diagnostic Data Type, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for AI Imaging & Diagnostics companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is AI Imaging & Diagnostics Market growing?

Ans: The AI Imaging & Diagnostics Market witnessing a CAGR of 20.9% during the forecast period 2026-2032.

What is the AI Imaging & Diagnostics Market size in 2032?

Ans: The AI Imaging & Diagnostics Market size in 2032 will be US$ 27453 million.

Who are the main players in the AI Imaging & Diagnostics Market report?

Ans: The main players in the AI Imaging & Diagnostics Market are Butterfly Network, Merative, Tempus, RetinAi, Nanox, Lunit, DiA Imaging, Subtle Medical, BrainMiner, GE, Siemens, Aidoc, Imagen Technologies, Inc., VUNO, Inc., Digital Diagnostics, NeuraSignal, Riverain Technologies, LLC, Philips, Microsoft, Viz.ai, RapidAI, Canon Medical, Enlitic, BioMind, ANNALISE-AI PTY LTD, icometrix, KONFOONG BIOTECH INTERNATIONAL CO., LTD（KFBIO）

What are the Application segmentation covered in the AI Imaging & Diagnostics Market report?

Ans: The Applications covered in the AI Imaging & Diagnostics Market report are Radiology & Imaging, Cardiology, Neurology, Ophthalmology, Oncology, Primary Care, Others

What are the Type segmentation covered in the AI Imaging & Diagnostics Market report?

Ans: The Types covered in the AI Imaging & Diagnostics Market report are Medical Imaging–based, Physiological Signals–based, Ophthalmic Imaging–based, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global AI Imaging & Diagnostics Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 X-ray / CXR

1.2.3 CT

1.2.4 MRI

1.2.5 Ultrasound

1.2.6 Mammography / DBT

1.2.7 Others

1.3 Market by Diagnostic Data Type

1.3.1 Global AI Imaging & Diagnostics Market Size Growth Rate by Diagnostic Data Type: 2021 vs 2025 vs 2032

1.3.2 Medical Imaging–based

1.3.3 Physiological Signals–based

1.3.4 Ophthalmic Imaging–based

1.3.5 Others

1.4 Market by Deployment & Delivery

1.4.1 Global AI Imaging & Diagnostics Market Size Growth Rate by Deployment & Delivery: 2021 vs 2025 vs 2032

1.4.2 On-prem

1.4.3 Cloud SaaS

1.4.4 Edge / Embedded

1.4.5 Hybrid

1.4.6 Others

1.5 Market by Application

1.5.1 Global AI Imaging & Diagnostics Market Growth by Application: 2021 vs 2025 vs 2032

1.5.2 Radiology & Imaging

1.5.3 Cardiology

1.5.4 Neurology

1.5.5 Ophthalmology

1.5.6 Oncology

1.5.7 Primary Care

1.5.8 Others

1.6 Assumptions and Limitations

1.7 Study Objectives

1.8 Years Considered

2 Global Growth Trends

2.1 Global AI Imaging & Diagnostics Market Perspective (2021–2032)

2.2 Global AI Imaging & Diagnostics Growth Trends by Region

2.2.1 Global AI Imaging & Diagnostics Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 AI Imaging & Diagnostics Historic Market Size by Region (2021–2026)

2.2.3 AI Imaging & Diagnostics Forecasted Market Size by Region (2027–2032)

2.3 AI Imaging & Diagnostics Market Dynamics

2.3.1 AI Imaging & Diagnostics Industry Trends

2.3.2 AI Imaging & Diagnostics Market Drivers

2.3.3 AI Imaging & Diagnostics Market Challenges

2.3.4 AI Imaging & Diagnostics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top AI Imaging & Diagnostics Players by Revenue

3.1.1 Global Top AI Imaging & Diagnostics Players by Revenue (2021–2026)

3.1.2 Global AI Imaging & Diagnostics Revenue Market Share by Players (2021–2026)

3.2 Global Top AI Imaging & Diagnostics Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by AI Imaging & Diagnostics Revenue

3.4 Global AI Imaging & Diagnostics Market Concentration Ratio

3.4.1 Global AI Imaging & Diagnostics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by AI Imaging & Diagnostics Revenue in 2025

3.5 Global Key Players of AI Imaging & Diagnostics Head Offices and Areas Served

3.6 Global Key Players of AI Imaging & Diagnostics, Products and Applications

3.7 Global Key Players of AI Imaging & Diagnostics, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 AI Imaging & Diagnostics Breakdown Data by Type

4.1 Global AI Imaging & Diagnostics Historic Market Size by Type (2021–2026)

4.2 Global AI Imaging & Diagnostics Forecasted Market Size by Type (2027–2032)

5 AI Imaging & Diagnostics Breakdown Data by Application

5.1 Global AI Imaging & Diagnostics Historic Market Size by Application (2021–2026)

5.2 Global AI Imaging & Diagnostics Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America AI Imaging & Diagnostics Market Size (2021–2032)

6.2 North America AI Imaging & Diagnostics Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America AI Imaging & Diagnostics Market Size by Country (2021–2026)

6.4 North America AI Imaging & Diagnostics Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe AI Imaging & Diagnostics Market Size (2021–2032)

7.2 Europe AI Imaging & Diagnostics Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe AI Imaging & Diagnostics Market Size by Country (2021–2026)

7.4 Europe AI Imaging & Diagnostics Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific AI Imaging & Diagnostics Market Size (2021–2032)

8.2 Asia-Pacific AI Imaging & Diagnostics Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific AI Imaging & Diagnostics Market Size by Region (2021–2026)

8.4 Asia-Pacific AI Imaging & Diagnostics Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America AI Imaging & Diagnostics Market Size (2021–2032)

9.2 Latin America AI Imaging & Diagnostics Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America AI Imaging & Diagnostics Market Size by Country (2021–2026)

9.4 Latin America AI Imaging & Diagnostics Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa AI Imaging & Diagnostics Market Size (2021–2032)

10.2 Middle East & Africa AI Imaging & Diagnostics Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa AI Imaging & Diagnostics Market Size by Country (2021–2026)

10.4 Middle East & Africa AI Imaging & Diagnostics Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Butterfly Network

11.1.1 Butterfly Network Company Details

11.1.2 Butterfly Network Business Overview

11.1.3 Butterfly Network AI Imaging & Diagnostics Introduction

11.1.4 Butterfly Network Revenue in AI Imaging & Diagnostics Business (2021–2026)

11.1.5 Butterfly Network Recent Development

11.2 Merative

11.2.1 Merative Company Details

11.2.2 Merative Business Overview

11.2.3 Merative AI Imaging & Diagnostics Introduction

11.2.4 Merative Revenue in AI Imaging & Diagnostics Business (2021–2026)

11.2.5 Merative Recent Development

11.3 Tempus

11.3.1 Tempus Company Details

11.3.2 Tempus Business Overview

11.3.3 Tempus AI Imaging & Diagnostics Introduction

11.3.4 Tempus Revenue in AI Imaging & Diagnostics Business (2021–2026)

11.3.5 Tempus Recent Development

11.4 RetinAi

11.4.1 RetinAi Company Details

11.4.2 RetinAi Business Overview

11.4.3 RetinAi AI Imaging & Diagnostics Introduction

11.4.4 RetinAi Revenue in AI Imaging & Diagnostics Business (2021–2026)

11.4.5 RetinAi Recent Development

11.5 Nanox

11.5.1 Nanox Company Details

11.5.2 Nanox Business Overview

11.5.3 Nanox AI Imaging & Diagnostics Introduction

11.5.4 Nanox Revenue in AI Imaging & Diagnostics Business (2021–2026)

11.5.5 Nanox Recent Development

11.6 Lunit

11.6.1 Lunit Company Details

11.6.2 Lunit Business Overview

11.6.3 Lunit AI Imaging & Diagnostics Introduction

11.6.4 Lunit Revenue in AI Imaging & Diagnostics Business (2021–2026)

11.6.5 Lunit Recent Development

11.7 DiA Imaging

11.7.1 DiA Imaging Company Details

11.7.2 DiA Imaging Business Overview

11.7.3 DiA Imaging AI Imaging & Diagnostics Introduction

11.7.4 DiA Imaging Revenue in AI Imaging & Diagnostics Business (2021–2026)

11.7.5 DiA Imaging Recent Development

11.8 Subtle Medical

11.8.1 Subtle Medical Company Details

11.8.2 Subtle Medical Business Overview

11.8.3 Subtle Medical AI Imaging & Diagnostics Introduction

11.8.4 Subtle Medical Revenue in AI Imaging & Diagnostics Business (2021–2026)

11.8.5 Subtle Medical Recent Development

11.9 BrainMiner

11.9.1 BrainMiner Company Details

11.9.2 BrainMiner Business Overview

11.9.3 BrainMiner AI Imaging & Diagnostics Introduction

11.9.4 BrainMiner Revenue in AI Imaging & Diagnostics Business (2021–2026)

11.9.5 BrainMiner Recent Development

11.10 GE

11.10.1 GE Company Details

11.10.2 GE Business Overview

11.10.3 GE AI Imaging & Diagnostics Introduction

11.10.4 GE Revenue in AI Imaging & Diagnostics Business (2021–2026)

11.10.5 GE Recent Development

11.11 Siemens

11.11.1 Siemens Company Details

11.11.2 Siemens Business Overview

11.11.3 Siemens AI Imaging & Diagnostics Introduction

11.11.4 Siemens Revenue in AI Imaging & Diagnostics Business (2021–2026)

11.11.5 Siemens Recent Development

11.12 Aidoc

11.12.1 Aidoc Company Details

11.12.2 Aidoc Business Overview

11.12.3 Aidoc AI Imaging & Diagnostics Introduction

11.12.4 Aidoc Revenue in AI Imaging & Diagnostics Business (2021–2026)

11.12.5 Aidoc Recent Development

11.13 Imagen Technologies, Inc.

11.13.1 Imagen Technologies, Inc. Company Details

11.13.2 Imagen Technologies, Inc. Business Overview

11.13.3 Imagen Technologies, Inc. AI Imaging & Diagnostics Introduction

11.13.4 Imagen Technologies, Inc. Revenue in AI Imaging & Diagnostics Business (2021–2026)

11.13.5 Imagen Technologies, Inc. Recent Development

11.14 VUNO, Inc.

11.14.1 VUNO, Inc. Company Details

11.14.2 VUNO, Inc. Business Overview

11.14.3 VUNO, Inc. AI Imaging & Diagnostics Introduction

11.14.4 VUNO, Inc. Revenue in AI Imaging & Diagnostics Business (2021–2026)

11.14.5 VUNO, Inc. Recent Development

11.15 Digital Diagnostics

11.15.1 Digital Diagnostics Company Details

11.15.2 Digital Diagnostics Business Overview

11.15.3 Digital Diagnostics AI Imaging & Diagnostics Introduction

11.15.4 Digital Diagnostics Revenue in AI Imaging & Diagnostics Business (2021–2026)

11.15.5 Digital Diagnostics Recent Development

11.16 NeuraSignal

11.16.1 NeuraSignal Company Details

11.16.2 NeuraSignal Business Overview

11.16.3 NeuraSignal AI Imaging & Diagnostics Introduction

11.16.4 NeuraSignal Revenue in AI Imaging & Diagnostics Business (2021–2026)

11.16.5 NeuraSignal Recent Development

11.17 Riverain Technologies, LLC

11.17.1 Riverain Technologies, LLC Company Details

11.17.2 Riverain Technologies, LLC Business Overview

11.17.3 Riverain Technologies, LLC AI Imaging & Diagnostics Introduction

11.17.4 Riverain Technologies, LLC Revenue in AI Imaging & Diagnostics Business (2021–2026)

11.17.5 Riverain Technologies, LLC Recent Development

11.18 Philips

11.18.1 Philips Company Details

11.18.2 Philips Business Overview

11.18.3 Philips AI Imaging & Diagnostics Introduction

11.18.4 Philips Revenue in AI Imaging & Diagnostics Business (2021–2026)

11.18.5 Philips Recent Development

11.19 Microsoft

11.19.1 Microsoft Company Details

11.19.2 Microsoft Business Overview

11.19.3 Microsoft AI Imaging & Diagnostics Introduction

11.19.4 Microsoft Revenue in AI Imaging & Diagnostics Business (2021–2026)

11.19.5 Microsoft Recent Development

11.20 Viz.ai

11.20.1 Viz.ai Company Details

11.20.2 Viz.ai Business Overview

11.20.3 Viz.ai AI Imaging & Diagnostics Introduction

11.20.4 Viz.ai Revenue in AI Imaging & Diagnostics Business (2021–2026)

11.20.5 Viz.ai Recent Development

11.21 RapidAI

11.21.1 RapidAI Company Details

11.21.2 RapidAI Business Overview

11.21.3 RapidAI AI Imaging & Diagnostics Introduction

11.21.4 RapidAI Revenue in AI Imaging & Diagnostics Business (2021–2026)

11.21.5 RapidAI Recent Development

11.22 Canon Medical

11.22.1 Canon Medical Company Details

11.22.2 Canon Medical Business Overview

11.22.3 Canon Medical AI Imaging & Diagnostics Introduction

11.22.4 Canon Medical Revenue in AI Imaging & Diagnostics Business (2021–2026)

11.22.5 Canon Medical Recent Development

11.23 Enlitic

11.23.1 Enlitic Company Details

11.23.2 Enlitic Business Overview

11.23.3 Enlitic AI Imaging & Diagnostics Introduction

11.23.4 Enlitic Revenue in AI Imaging & Diagnostics Business (2021–2026)

11.23.5 Enlitic Recent Development

11.24 BioMind

11.24.1 BioMind Company Details

11.24.2 BioMind Business Overview

11.24.3 BioMind AI Imaging & Diagnostics Introduction

11.24.4 BioMind Revenue in AI Imaging & Diagnostics Business (2021–2026)

11.24.5 BioMind Recent Development

11.25 ANNALISE-AI PTY LTD

11.25.1 ANNALISE-AI PTY LTD Company Details

11.25.2 ANNALISE-AI PTY LTD Business Overview

11.25.3 ANNALISE-AI PTY LTD AI Imaging & Diagnostics Introduction

11.25.4 ANNALISE-AI PTY LTD Revenue in AI Imaging & Diagnostics Business (2021–2026)

11.25.5 ANNALISE-AI PTY LTD Recent Development

11.26 icometrix

11.26.1 icometrix Company Details

11.26.2 icometrix Business Overview

11.26.3 icometrix AI Imaging & Diagnostics Introduction

11.26.4 icometrix Revenue in AI Imaging & Diagnostics Business (2021–2026)

11.26.5 icometrix Recent Development

11.27 KONFOONG BIOTECH INTERNATIONAL CO., LTD（KFBIO）

11.27.1 KONFOONG BIOTECH INTERNATIONAL CO., LTD（KFBIO） Company Details

11.27.2 KONFOONG BIOTECH INTERNATIONAL CO., LTD（KFBIO） Business Overview

11.27.3 KONFOONG BIOTECH INTERNATIONAL CO., LTD（KFBIO） AI Imaging & Diagnostics Introduction

11.27.4 KONFOONG BIOTECH INTERNATIONAL CO., LTD（KFBIO） Revenue in AI Imaging & Diagnostics Business (2021–2026)

11.27.5 KONFOONG BIOTECH INTERNATIONAL CO., LTD（KFBIO） Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

List of Tables

Table 1. Global AI Imaging & Diagnostics Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of X-ray / CXR

Table 3. Key Players of CT

Table 4. Key Players of MRI

Table 5. Key Players of Ultrasound

Table 6. Key Players of Mammography / DBT

Table 7. Key Players of Others

Table 8. Global AI Imaging & Diagnostics Market Size Growth Rate by Diagnostic Data Type (US$ Million): 2021 vs 2025 vs 2032

Table 9. Key Players of Medical Imaging–based

Table 10. Key Players of Physiological Signals–based

Table 11. Key Players of Ophthalmic Imaging–based

Table 12. Key Players of Others

Table 13. Global AI Imaging & Diagnostics Market Size Growth Rate by Deployment & Delivery (US$ Million): 2021 vs 2025 vs 2032

Table 14. Key Players of On-prem

Table 15. Key Players of Cloud SaaS

Table 16. Key Players of Edge / Embedded

Table 17. Key Players of Hybrid

Table 18. Key Players of Others

Table 19. Global AI Imaging & Diagnostics Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 20. Global AI Imaging & Diagnostics Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 21. Global AI Imaging & Diagnostics Market Size by Region (US$ Million), 2021–2026

Table 22. Global AI Imaging & Diagnostics Market Share by Region (2021–2026)

Table 23. Global AI Imaging & Diagnostics Forecasted Market Size by Region (US$ Million), 2027–2032

Table 24. Global AI Imaging & Diagnostics Market Share by Region (2027–2032)

Table 25. AI Imaging & Diagnostics Market Trends

Table 26. AI Imaging & Diagnostics Market Drivers

Table 27. AI Imaging & Diagnostics Market Challenges

Table 28. AI Imaging & Diagnostics Market Restraints

Table 29. Global AI Imaging & Diagnostics Revenue by Players (US$ Million), 2021–2026

Table 30. Global AI Imaging & Diagnostics Market Share by Players (2021–2026)

Table 31. Global Top AI Imaging & Diagnostics Players by Tier (Tier 1, Tier 2, and Tier 3), based on AI Imaging & Diagnostics Revenue, 2025

Table 32. Ranking of Global Top AI Imaging & Diagnostics Companies by Revenue (US$ Million) in 2025

Table 33. Global 5 Largest Players Market Share by AI Imaging & Diagnostics Revenue (CR5 and HHI), 2021–2026

Table 34. Global Key Players of AI Imaging & Diagnostics, Headquarters and Area Served

Table 35. Global Key Players of AI Imaging & Diagnostics, Products and Applications

Table 36. Global Key Players of AI Imaging & Diagnostics, Date of General Availability (GA)

Table 37. Mergers and Acquisitions, Expansion Plans

Table 38. Global AI Imaging & Diagnostics Market Size by Type (US$ Million), 2021–2026

Table 39. Global AI Imaging & Diagnostics Revenue Market Share by Type (2021–2026)

Table 40. Global AI Imaging & Diagnostics Forecasted Market Size by Type (US$ Million), 2027–2032

Table 41. Global AI Imaging & Diagnostics Revenue Market Share by Type (2027–2032)

Table 42. Global AI Imaging & Diagnostics Market Size by Application (US$ Million), 2021–2026

Table 43. Global AI Imaging & Diagnostics Revenue Market Share by Application (2021–2026)

Table 44. Global AI Imaging & Diagnostics Forecasted Market Size by Application (US$ Million), 2027–2032

Table 45. Global AI Imaging & Diagnostics Revenue Market Share by Application (2027–2032)

Table 46. North America AI Imaging & Diagnostics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 47. North America AI Imaging & Diagnostics Market Size by Country (US$ Million), 2021–2026

Table 48. North America AI Imaging & Diagnostics Market Size by Country (US$ Million), 2027–2032

Table 49. Europe AI Imaging & Diagnostics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 50. Europe AI Imaging & Diagnostics Market Size by Country (US$ Million), 2021–2026

Table 51. Europe AI Imaging & Diagnostics Market Size by Country (US$ Million), 2027–2032

Table 52. Asia-Pacific AI Imaging & Diagnostics Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 53. Asia-Pacific AI Imaging & Diagnostics Market Size by Region (US$ Million), 2021–2026

Table 54. Asia-Pacific AI Imaging & Diagnostics Market Size by Region (US$ Million), 2027–2032

Table 55. Latin America AI Imaging & Diagnostics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 56. Latin America AI Imaging & Diagnostics Market Size by Country (US$ Million), 2021–2026

Table 57. Latin America AI Imaging & Diagnostics Market Size by Country (US$ Million), 2027–2032

Table 58. Middle East & Africa AI Imaging & Diagnostics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 59. Middle East & Africa AI Imaging & Diagnostics Market Size by Country (US$ Million), 2021–2026

Table 60. Middle East & Africa AI Imaging & Diagnostics Market Size by Country (US$ Million), 2027–2032

Table 61. Butterfly Network Company Details

Table 62. Butterfly Network Business Overview

Table 63. Butterfly Network AI Imaging & Diagnostics Product

Table 64. Butterfly Network Revenue in AI Imaging & Diagnostics Business (US$ Million), 2021–2026

Table 65. Butterfly Network Recent Development

Table 66. Merative Company Details

Table 67. Merative Business Overview

Table 68. Merative AI Imaging & Diagnostics Product

Table 69. Merative Revenue in AI Imaging & Diagnostics Business (US$ Million), 2021–2026

Table 70. Merative Recent Development

Table 71. Tempus Company Details

Table 72. Tempus Business Overview

Table 73. Tempus AI Imaging & Diagnostics Product

Table 74. Tempus Revenue in AI Imaging & Diagnostics Business (US$ Million), 2021–2026

Table 75. Tempus Recent Development

Table 76. RetinAi Company Details

Table 77. RetinAi Business Overview

Table 78. RetinAi AI Imaging & Diagnostics Product

Table 79. RetinAi Revenue in AI Imaging & Diagnostics Business (US$ Million), 2021–2026

Table 80. RetinAi Recent Development

Table 81. Nanox Company Details

Table 82. Nanox Business Overview

Table 83. Nanox AI Imaging & Diagnostics Product

Table 84. Nanox Revenue in AI Imaging & Diagnostics Business (US$ Million), 2021–2026

Table 85. Nanox Recent Development

Table 86. Lunit Company Details

Table 87. Lunit Business Overview

Table 88. Lunit AI Imaging & Diagnostics Product

Table 89. Lunit Revenue in AI Imaging & Diagnostics Business (US$ Million), 2021–2026

Table 90. Lunit Recent Development

Table 91. DiA Imaging Company Details

Table 92. DiA Imaging Business Overview

Table 93. DiA Imaging AI Imaging & Diagnostics Product

Table 94. DiA Imaging Revenue in AI Imaging & Diagnostics Business (US$ Million), 2021–2026

Table 95. DiA Imaging Recent Development

Table 96. Subtle Medical Company Details

Table 97. Subtle Medical Business Overview

Table 98. Subtle Medical AI Imaging & Diagnostics Product

Table 99. Subtle Medical Revenue in AI Imaging & Diagnostics Business (US$ Million), 2021–2026

Table 100. Subtle Medical Recent Development

Table 101. BrainMiner Company Details

Table 102. BrainMiner Business Overview

Table 103. BrainMiner AI Imaging & Diagnostics Product

Table 104. BrainMiner Revenue in AI Imaging & Diagnostics Business (US$ Million), 2021–2026

Table 105. BrainMiner Recent Development

Table 106. GE Company Details

Table 107. GE Business Overview

Table 108. GE AI Imaging & Diagnostics Product

Table 109. GE Revenue in AI Imaging & Diagnostics Business (US$ Million), 2021–2026

Table 110. GE Recent Development

Table 111. Siemens Company Details

Table 112. Siemens Business Overview

Table 113. Siemens AI Imaging & Diagnostics Product

Table 114. Siemens Revenue in AI Imaging & Diagnostics Business (US$ Million), 2021–2026

Table 115. Siemens Recent Development

Table 116. Aidoc Company Details

Table 117. Aidoc Business Overview

Table 118. Aidoc AI Imaging & Diagnostics Product

Table 119. Aidoc Revenue in AI Imaging & Diagnostics Business (US$ Million), 2021–2026

Table 120. Aidoc Recent Development

Table 121. Imagen Technologies, Inc. Company Details

Table 122. Imagen Technologies, Inc. Business Overview

Table 123. Imagen Technologies, Inc. AI Imaging & Diagnostics Product

Table 124. Imagen Technologies, Inc. Revenue in AI Imaging & Diagnostics Business (US$ Million), 2021–2026

Table 125. Imagen Technologies, Inc. Recent Development

Table 126. VUNO, Inc. Company Details

Table 127. VUNO, Inc. Business Overview

Table 128. VUNO, Inc. AI Imaging & Diagnostics Product

Table 129. VUNO, Inc. Revenue in AI Imaging & Diagnostics Business (US$ Million), 2021–2026

Table 130. VUNO, Inc. Recent Development

Table 131. Digital Diagnostics Company Details

Table 132. Digital Diagnostics Business Overview

Table 133. Digital Diagnostics AI Imaging & Diagnostics Product

Table 134. Digital Diagnostics Revenue in AI Imaging & Diagnostics Business (US$ Million), 2021–2026

Table 135. Digital Diagnostics Recent Development

Table 136. NeuraSignal Company Details

Table 137. NeuraSignal Business Overview

Table 138. NeuraSignal AI Imaging & Diagnostics Product

Table 139. NeuraSignal Revenue in AI Imaging & Diagnostics Business (US$ Million), 2021–2026

Table 140. NeuraSignal Recent Development

Table 141. Riverain Technologies, LLC Company Details

Table 142. Riverain Technologies, LLC Business Overview

Table 143. Riverain Technologies, LLC AI Imaging & Diagnostics Product

Table 144. Riverain Technologies, LLC Revenue in AI Imaging & Diagnostics Business (US$ Million), 2021–2026

Table 145. Riverain Technologies, LLC Recent Development

Table 146. Philips Company Details

Table 147. Philips Business Overview

Table 148. Philips AI Imaging & Diagnostics Product

Table 149. Philips Revenue in AI Imaging & Diagnostics Business (US$ Million), 2021–2026

Table 150. Philips Recent Development

Table 151. Microsoft Company Details

Table 152. Microsoft Business Overview

Table 153. Microsoft AI Imaging & Diagnostics Product

Table 154. Microsoft Revenue in AI Imaging & Diagnostics Business (US$ Million), 2021–2026

Table 155. Microsoft Recent Development

Table 156. Viz.ai Company Details

Table 157. Viz.ai Business Overview

Table 158. Viz.ai AI Imaging & Diagnostics Product

Table 159. Viz.ai Revenue in AI Imaging & Diagnostics Business (US$ Million), 2021–2026

Table 160. Viz.ai Recent Development

Table 161. RapidAI Company Details

Table 162. RapidAI Business Overview

Table 163. RapidAI AI Imaging & Diagnostics Product

Table 164. RapidAI Revenue in AI Imaging & Diagnostics Business (US$ Million), 2021–2026

Table 165. RapidAI Recent Development

Table 166. Canon Medical Company Details

Table 167. Canon Medical Business Overview

Table 168. Canon Medical AI Imaging & Diagnostics Product

Table 169. Canon Medical Revenue in AI Imaging & Diagnostics Business (US$ Million), 2021–2026

Table 170. Canon Medical Recent Development

Table 171. Enlitic Company Details

Table 172. Enlitic Business Overview

Table 173. Enlitic AI Imaging & Diagnostics Product

Table 174. Enlitic Revenue in AI Imaging & Diagnostics Business (US$ Million), 2021–2026

Table 175. Enlitic Recent Development

Table 176. BioMind Company Details

Table 177. BioMind Business Overview

Table 178. BioMind AI Imaging & Diagnostics Product

Table 179. BioMind Revenue in AI Imaging & Diagnostics Business (US$ Million), 2021–2026

Table 180. BioMind Recent Development

Table 181. ANNALISE-AI PTY LTD Company Details

Table 182. ANNALISE-AI PTY LTD Business Overview

Table 183. ANNALISE-AI PTY LTD AI Imaging & Diagnostics Product

Table 184. ANNALISE-AI PTY LTD Revenue in AI Imaging & Diagnostics Business (US$ Million), 2021–2026

Table 185. ANNALISE-AI PTY LTD Recent Development

Table 186. icometrix Company Details

Table 187. icometrix Business Overview

Table 188. icometrix AI Imaging & Diagnostics Product

Table 189. icometrix Revenue in AI Imaging & Diagnostics Business (US$ Million), 2021–2026

Table 190. icometrix Recent Development

Table 191. KONFOONG BIOTECH INTERNATIONAL CO., LTD（KFBIO） Company Details

Table 192. KONFOONG BIOTECH INTERNATIONAL CO., LTD（KFBIO） Business Overview

Table 193. KONFOONG BIOTECH INTERNATIONAL CO., LTD（KFBIO） AI Imaging & Diagnostics Product

Table 194. KONFOONG BIOTECH INTERNATIONAL CO., LTD（KFBIO） Revenue in AI Imaging & Diagnostics Business (US$ Million), 2021–2026

Table 195. KONFOONG BIOTECH INTERNATIONAL CO., LTD（KFBIO） Recent Development

Table 196. Research Programs/Design for This Report

Table 197. Key Data Information from Secondary Sources

Table 198. Key Data Information from Primary Sources

Table 199. Authors List of This Report

List of Figures

Figure 1. AI Imaging & Diagnostics Picture

Figure 2. Global AI Imaging & Diagnostics Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global AI Imaging & Diagnostics Market Share by Type: 2025 vs 2032

Figure 4. X-ray / CXR Features

Figure 5. CT Features

Figure 6. MRI Features

Figure 7. Ultrasound Features

Figure 8. Mammography / DBT Features

Figure 9. Others Features

Figure 10. Global AI Imaging & Diagnostics Market Size Comparison by Diagnostic Data Type (US$ Million), 2021–2032

Figure 11. Medical Imaging–based Features

Figure 12. Physiological Signals–based Features

Figure 13. Ophthalmic Imaging–based Features

Figure 14. Others Features

Figure 15. Global AI Imaging & Diagnostics Market Size Comparison by Deployment & Delivery (US$ Million), 2021–2032

Figure 16. On-prem Features

Figure 17. Cloud SaaS Features

Figure 18. Edge / Embedded Features

Figure 19. Hybrid Features

Figure 20. Others Features

Figure 21. Global AI Imaging & Diagnostics Market Size by Application (US$ Million), 2021–2032

Figure 22. Global AI Imaging & Diagnostics Market Share by Application: 2025 vs 2032

Figure 23. Radiology & Imaging Case Studies

Figure 24. Cardiology Case Studies

Figure 25. Neurology Case Studies

Figure 26. Ophthalmology Case Studies

Figure 27. Oncology Case Studies

Figure 28. Primary Care Case Studies

Figure 29. Others Case Studies

Figure 30. AI Imaging & Diagnostics Report Years Considered

Figure 31. Global AI Imaging & Diagnostics Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 32. Global AI Imaging & Diagnostics Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 33. Global AI Imaging & Diagnostics Market Share by Region: 2025 vs 2032

Figure 34. Global AI Imaging & Diagnostics Market Share by Players in 2025

Figure 35. Global AI Imaging & Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 36. The Top 10 and 5 Players Market Share by AI Imaging & Diagnostics Revenue in 2025

Figure 37. North America AI Imaging & Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. North America AI Imaging & Diagnostics Market Share by Country (2021–2032)

Figure 39. United States AI Imaging & Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Canada AI Imaging & Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Europe AI Imaging & Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Europe AI Imaging & Diagnostics Market Share by Country (2021–2032)

Figure 43. Germany AI Imaging & Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. France AI Imaging & Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. U.K. AI Imaging & Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Italy AI Imaging & Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Russia AI Imaging & Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. Ireland AI Imaging & Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 49. Asia-Pacific AI Imaging & Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 50. Asia-Pacific AI Imaging & Diagnostics Market Share by Region (2021–2032)

Figure 51. China AI Imaging & Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 52. Japan AI Imaging & Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 53. South Korea AI Imaging & Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 54. Southeast Asia AI Imaging & Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 55. India AI Imaging & Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 56. Australia & New Zealand AI Imaging & Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 57. Latin America AI Imaging & Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 58. Latin America AI Imaging & Diagnostics Market Share by Country (2021–2032)

Figure 59. Mexico AI Imaging & Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 60. Brazil AI Imaging & Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 61. Middle East & Africa AI Imaging & Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 62. Middle East & Africa AI Imaging & Diagnostics Market Share by Country (2021–2032)

Figure 63. Israel AI Imaging & Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 64. Saudi Arabia AI Imaging & Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 65. UAE AI Imaging & Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 66. Butterfly Network Revenue Growth Rate in AI Imaging & Diagnostics Business (2021–2026)

Figure 67. Merative Revenue Growth Rate in AI Imaging & Diagnostics Business (2021–2026)

Figure 68. Tempus Revenue Growth Rate in AI Imaging & Diagnostics Business (2021–2026)

Figure 69. RetinAi Revenue Growth Rate in AI Imaging & Diagnostics Business (2021–2026)

Figure 70. Nanox Revenue Growth Rate in AI Imaging & Diagnostics Business (2021–2026)

Figure 71. Lunit Revenue Growth Rate in AI Imaging & Diagnostics Business (2021–2026)

Figure 72. DiA Imaging Revenue Growth Rate in AI Imaging & Diagnostics Business (2021–2026)

Figure 73. Subtle Medical Revenue Growth Rate in AI Imaging & Diagnostics Business (2021–2026)

Figure 74. BrainMiner Revenue Growth Rate in AI Imaging & Diagnostics Business (2021–2026)

Figure 75. GE Revenue Growth Rate in AI Imaging & Diagnostics Business (2021–2026)

Figure 76. Siemens Revenue Growth Rate in AI Imaging & Diagnostics Business (2021–2026)

Figure 77. Aidoc Revenue Growth Rate in AI Imaging & Diagnostics Business (2021–2026)

Figure 78. Imagen Technologies, Inc. Revenue Growth Rate in AI Imaging & Diagnostics Business (2021–2026)

Figure 79. VUNO, Inc. Revenue Growth Rate in AI Imaging & Diagnostics Business (2021–2026)

Figure 80. Digital Diagnostics Revenue Growth Rate in AI Imaging & Diagnostics Business (2021–2026)

Figure 81. NeuraSignal Revenue Growth Rate in AI Imaging & Diagnostics Business (2021–2026)

Figure 82. Riverain Technologies, LLC Revenue Growth Rate in AI Imaging & Diagnostics Business (2021–2026)

Figure 83. Philips Revenue Growth Rate in AI Imaging & Diagnostics Business (2021–2026)

Figure 84. Microsoft Revenue Growth Rate in AI Imaging & Diagnostics Business (2021–2026)

Figure 85. Viz.ai Revenue Growth Rate in AI Imaging & Diagnostics Business (2021–2026)

Figure 86. RapidAI Revenue Growth Rate in AI Imaging & Diagnostics Business (2021–2026)

Figure 87. Canon Medical Revenue Growth Rate in AI Imaging & Diagnostics Business (2021–2026)

Figure 88. Enlitic Revenue Growth Rate in AI Imaging & Diagnostics Business (2021–2026)

Figure 89. BioMind Revenue Growth Rate in AI Imaging & Diagnostics Business (2021–2026)

Figure 90. ANNALISE-AI PTY LTD Revenue Growth Rate in AI Imaging & Diagnostics Business (2021–2026)

Figure 91. icometrix Revenue Growth Rate in AI Imaging & Diagnostics Business (2021–2026)

Figure 92. KONFOONG BIOTECH INTERNATIONAL CO., LTD（KFBIO） Revenue Growth Rate in AI Imaging & Diagnostics Business (2021–2026)

Figure 93. Bottom-up and Top-down Approaches for This Report

Figure 94. Data Triangulation

Figure 95. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global AI Imaging & Diagnostics Market Research Report 2026

Published Date: 2026-01-08

Report Code: QYRE-Auto-22S20079

Global AI Imaging & Diagnostics Market Research Report 2026

FEATURED COMPANIES

AI Imaging & Diagnostics Market Size

AI Imaging & Diagnostics Market

Scope of AI Imaging & Diagnostics Market Report

Chapter Outline

FAQ for this report

How fast is AI Imaging & Diagnostics Market growing?

What is the AI Imaging & Diagnostics Market size in 2032?

Who are the main players in the AI Imaging & Diagnostics Market report?

What are the Application segmentation covered in the AI Imaging & Diagnostics Market report?

What are the Type segmentation covered in the AI Imaging & Diagnostics Market report?

FEATURED COMPANIES